NCT02606981

Brief Summary

Municipal water networks within industrialized countries typically rely on centralized treatment to manage piped water quality. Optimal water quality at the tap, however, requires well-maintained piped distribution networks, and performs best when piped systems are fully pressurized. In low-income cities such as Dhaka, water distribution networks are inadequately maintained and typically supply intermittent service; as such, they are vulnerable to recontamination during negative pressure events. Among populations accessing these types of improved water sources in urban settings (e.g. shared taps), it is unknown if consistent treatment to provide chlorinated water at the point of collection would have a significant health benefit. Furthermore, almost all previous studies of water treatment interventions in low-income countries have been unblinded with self-reported diarrhea as the main outcome, casting doubt that reported impacts of water disinfection on diarrhea are not due entirely to social desirability bias. Stanford University in collaboration with icddr,b will conduct a randomized evaluation to assess the impact on access to automatically chlorinated water on water quality and child health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,549

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 20, 2015

Completed
28 days until next milestone

First Posted

Study publicly available on registry

November 17, 2015

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2016

Completed
Last Updated

May 12, 2017

Status Verified

May 1, 2017

Enrollment Period

1.5 years

First QC Date

October 20, 2015

Last Update Submit

May 10, 2017

Conditions

Keywords

Water treatmentChild growthEnteric infection

Outcome Measures

Primary Outcomes (1)

  • Diarrhea longitudinal prevalence

    1-week recall period, case definition is 3 or more loose/watery bowel movements in 24 hours

    Measured every 2-3 months for 16 months post baseline

Secondary Outcomes (7)

  • Weight-for-age-z-score

    Measured every 2-3 months for 16 months post baseline

  • Height-for-age-z-score

    Measured at baseline and 16 months after baseline

  • Respiratory illness longitudinal prevalence

    Measured every 2-3 months for 16 months post baseline

  • C-reactive protein

    Measured at baseline and conclusion of study (16 months post baseline) among children under five

  • total immunoglobin G (IgG)

    Measured at baseline and conclusion of study (16 months post baseline) among children under five

  • +2 more secondary outcomes

Other Outcomes (3)

  • Microbial water quality

    Measured monthly among a subset of households, for 16 months post baseline

  • Chlorine residual in household stored drinking water

    Measured every 2-3 months for 16 months post baseline

  • health related treatment and associated cost

    Measured every 2-3 months for 16 months post baseline

Study Arms (2)

Chlorination

EXPERIMENTAL

Device: Water chlorination by the Flogenic Primary drinking water source will be outfitted with automatic dosing device supplied with chlorine tablets. The device is called the Flogenic.

Device: Water chlorination by the Flogenic

Control

PLACEBO COMPARATOR

Active control: Vitamin C dosing into water. Primary drinking water source will be outfitted with automatic dosing device supplied with vitamin C tablets. The device is not commercially available.

Device: Active control, vitamin C dosing into water

Interventions

The chlorine doser delivers a constant amount of chlorine into water as it flows into a holding tank. The water is then piped to public and private taps.

Also known as: Flogenic by Medentech
Chlorination

The control group will receive a vitamin C dosing device that looks identical to the intervention chlorine doser installed in the holding tank that feeds their shared water access point.

Also known as: Vitamin C dosing device (not commercially available)
Control

Eligibility Criteria

AgeUp to 60 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Households with at least one child under 60 months old
  • Households using enrolled shared water point as primary drinking water source

You may not qualify if:

  • Households with a private drinking water source
  • Note: New births and children under 60 months that migrate into compounds accessing the enrolled water points for drinking water will be enrolled into the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tongi and Dhaka Uddan

Tongi/Dhaka, Gazipur, Bangladesh

Location

Related Publications (1)

  • Pickering AJ, Crider Y, Sultana S, Swarthout J, Goddard FG, Anjerul Islam S, Sen S, Ayyagari R, Luby SP. Effect of in-line drinking water chlorination at the point of collection on child diarrhoea in urban Bangladesh: a double-blind, cluster-randomised controlled trial. Lancet Glob Health. 2019 Sep;7(9):e1247-e1256. doi: 10.1016/S2214-109X(19)30315-8.

MeSH Terms

Conditions

DiarrheaCommunicable Diseases

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsInfectionsDisease AttributesPathologic Processes

Study Officials

  • Stephen Luby, MD

    Stanford University

    PRINCIPAL INVESTIGATOR
  • Amy Pickering, PhD

    Stanford University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

October 20, 2015

First Posted

November 17, 2015

Study Start

July 1, 2015

Primary Completion

December 20, 2016

Study Completion

December 20, 2016

Last Updated

May 12, 2017

Record last verified: 2017-05

Locations